# Iovance Biotherapeutics, Inc. Common Stock (IOVA)

Iovance Biotherapeutics (IOVA) sees strong social media buzz around upcoming clinical trial data and positive analyst ratings, despite recent stock price lows. Recent posts highlight the potential of Amtagvi and management's confidence, suggesting a potential turnaround.

### About Iovance Biotherapeutics, Inc. Common Stock
Iovance Biotherapeutics, Inc. is a biotechnology company focused on cancer immunotherapy.  
Iovance Biotherapeutics, Inc. Common Stock uses the ticker $IOVA for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Iovance Biotherapeutics, Inc. Common Stock (IOVA) social dominance is up 258.4% from the previous week.
- Iovance Biotherapeutics, Inc. Common Stock (IOVA) sentiment is up 40.85% from the previous week.

### Price: $2.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$iova/time-series/close.tsv)  
The stock is trading near its 52-week low, but increasing social media sentiment and anticipation of clinical trial data suggest a potential short squeeze is building, driven by undervaluation.  

24-Hour: 2.07%
7-Day: 2.39%
30-Day: 8.9%

1-Year High: $5.80 on 2025-02-21  
1-Year Low: $1.70 on 2025-05-16  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$iova/time-series/alt_rank.tsv)  
Iovance Biotherapeutics, Inc. Common Stock (IOVA) is currently AltRank #1,146 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +639  
[--] Month: [-----] +164  
[--] Months: [-----] +538  
[--] Year: [-----] +786  
1-Year High: [-----] on 2025-07-12  
1-Year Low: [--] on 2025-08-03  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$iova/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] +24  
[--] Months: [--] +4  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-12-17  
1-Year Low: [--] on 2025-09-12  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$iova/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] -9.80%  
[--] Month: [-------] -2.20%  
[--] Months: [---------] -21%  
[--] Year: [----------] -28%  
1-Year High: [-------] on 2025-07-23  
1-Year Low: [-----] on 2025-12-14  

Engagements by network (24h):
News: [--]
X: [------]
YouTube: [---]
TikTok: [--]
Reddit: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$iova/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] -5.70%  
[--] Month: [-----] +36%  
[--] Months: [-----] +2.90%  
[--] Year: [------] +6.10%  
1-Year High: [---] on 2025-07-31  
1-Year Low: [--] on 2025-09-14  

Mentions by network (24h):
News: [--]
X: [---]
YouTube: [--]
TikTok: [--]
Reddit: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$iova/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Iovance Biotherapeutics, Inc. Common Stock (IOVA) in the last [--] hours which is up 19% from [--] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] -10%  
[--] Month: [---] +2.30%  
[--] Months: [-----] -15%  
[--] Year: [-----] +109%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-14  

The most influential creators that mention Iovance Biotherapeutics, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@doepke_michel](/creator/twitter/doepke_michel)     | [--]    | [------]    | [--]     | [-----]       |
| [@BIOTECHSCANNER](/creator/twitter/BIOTECHSCANNER)   | [--]    | [-----]     | [--]    | [-----]       |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]    | [---]         |
| [@stocket_rocket](/creator/twitter/stocket_rocket)   | [--]    | [--]        | [--]     | [---]         |
| [@kainvests](/creator/twitter/kainvests)             | [--]    | [---]       | [--]     | [---]         |
| [@JanvDes](/creator/twitter/JanvDes)                 | [--]    | [--]        | [--]     | [---]         |
| [@DeepSouthDoctor](/creator/twitter/DeepSouthDoctor) | [--]    | [-----]     | [--]     | [---]         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]    | [---]         |
| [@jy201506](/creator/twitter/jy201506)               | [--]    | [---]       | [--]     | [---]         |
| [@mariostario2019](/creator/twitter/mariostario2019) | [--]   | [--]        | [--]     | [---]         |

[View More](/list/creators/$iova/100)
  
  
### Sentiment: 74%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$iova/time-series/sentiment.tsv)  
Current Value: 74%  
Daily Average: 75%  
[--] Week: 100% +29%  
[--] Month: 68% -8%  
[--] Months: 68% -17%  
[--] Year: 68% -9%  
1-Year High: 96% on 2025-08-21  
1-Year Low: 47% on 2025-12-10  

Most Supportive Themes:
- Clinical Trial Progress and Data Releases: (45%) Anticipation for upcoming clinical trial data, particularly for NSCLC and IOV 4001, is driving optimism.
- Analyst Ratings and Insider Confidence: (30%) HC Wainwright's 'buy' rating and increased insider stake signal positive sentiment.
- Partnership with McKesson: (25%) The collaboration with McKesson's InspiroGene for Amtagvi is viewed as a significant positive development.
  
Most Critical Themes:
- Stock Price Performance: (70%) Concerns persist regarding the stock's performance near a 52-week low and negative price trends across various timeframes.
- Market Dominance and Competition: (30%) The company faces challenges in market dominance and competition within the biotech sector.
  
  
  
### Social Dominance: 0.012%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$iova/time-series/social_dominance.tsv)  
Current Value: 0.012%  
Daily Average: 0.029%  
[--] Week: 0.045% +0.032%  
[--] Month: 0.024% +0.0088%  
[--] Months: 0.024% -0.0096%  
[--] Year: 0.024% -0.014%  
1-Year High: 0.09% on 2025-07-31  
1-Year Low: 0.0062% on 2025-09-14  
  
  
### Market Dominance: 0.00116%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$iova/time-series/market_dominance.tsv)  
Current Value: 0.00116%  
Daily Average: 0%  
1-Year High: 0.041% on 2025-03-31  
1-Year Low: 0.00074% on 2025-07-07  
  
  
### Market Cap: $1,021,041,316
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$iova/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$iova/time-series/market_cap.tsv)  
Current Value: $1,021,041,316  
Daily Average: $930,888,716  
[--] Week: $1,021,041,316 +2.50%  
[--] Month: $1,021,041,316 +16%  
[--] Months: $1,021,041,316 +13%  
[--] Year: $1,021,041,316 -40%  
1-Year High: $1,895,127,291 on 2025-02-21  
1-Year Low: $554,331,082 on 2025-05-16  

### Top Iovance Biotherapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$IOVA Key Things to Watch on the Call [--]. FY2025 Revenue I expect full-year [----] revenue to land toward the lower end of the companys $250M$300M guidance range. While recent developments appear constructive including onboarding of community ATCs and a potential shift toward earlier-line use of Amtagvi with lower patient dropout I believe these positive dynamics require one to two quarters to meaningfully translate into reported revenue. As a result the operational momentum may not yet be fully reflected in the FY2025 top line. [--]. 4Q2025 Gross Margin I anticipate gross margin to be broadly in"  
[X Link](https://x.com/jy201506/status/2022556742719000904) [@jy201506](/creator/x/jy201506) 2026-02-14T06:21Z [---] followers, [---] engagements


"$IOVA ⚠👀 Guys Don't miss the next move in a few hours. 💯🚀 https://discord.com/invite/cQZwYVnEGE https://discord.com/invite/cQZwYVnEGE"  
[X Link](https://x.com/Stock_Analysis4/status/2022373607314460712) [@Stock_Analysis4](/creator/x/Stock_Analysis4) 2026-02-13T18:13Z [--] followers, [---] engagements


"@jfais20 Strange comparison to make. $IOVA treatment centers need a surgery team ready to act fast. You are comparing that to cell therapy treatment centers"  
[X Link](https://x.com/AscendingBio/status/2022372410800906371) [@AscendingBio](/creator/x/AscendingBio) 2026-02-13T18:08Z [---] followers, [---] engagements


"$CRSP- guess who also has their ATCs in place $IOVA $CRSP Casgevy flywheel starting to move now that all ATCs have been onboarded. https://t.co/QXhNmZc38P $CRSP Casgevy flywheel starting to move now that all ATCs have been onboarded. https://t.co/QXhNmZc38P"  
[X Link](https://x.com/jfais20/status/2022356837157552150) [@jfais20](/creator/x/jfais20) 2026-02-13T17:06Z 11.5K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing